We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

8 Jun 2017 07:00

RNS Number : 4739H
Sopheon PLC
08 June 2017
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

At today's Annual General Meeting of Sopheon, the international provider of software and services that help organizations generate more revenues and profits from new products, the Board will give shareholders an update and review of the business.

 

It gives us great pleasure to report another year of excellent financial and operational progress, as we continue to advance our strategy of being the world's leading solution provider of enterprise-class innovation management software solutions. A year ago we were pleased to report solid strategic and financial progress, and we are delighted to say the same applies today, one year later. Last year we grew revenues to $23.2m from $20.9m in 2015 and $18.3m in 2014, and we delivered another substantial increase in profitability, with EBITDA rising to $5.2m before exchange gains ($5.6m including exchange gains) from $4.1m the year before, which was itself more than triple the 2014 performance. Profit before tax rose to $3.0m from $1.2m in 2015. In 2016 we also initiated partial recognition of our substantial deferred tax asset, which resulted in a profit after tax of $4.3m. Net assets nearly doubled to $10.4m from $5.5m in 2015.

 

The revenue growth was underpinned by a rise to 49 license transactions from 42 the year before, of which 17 were new customers, up from 14 in 2015. We continued to invest in and show traction with the two elements of our go-to-market strategy - both the global end-to-end enterprise solution, and the "out-of-the-box" Accolade Express solution for quicker time to value. Our market strength in the consumer products industry was again recognized, with Sopheon being voted a "top ten software vendor" for the seventh consecutive year by the CGT magazine readership. In addition to this progress, we also saw strong traction in the aerospace and defense and chemicals sectors. Sopheon's commercial success is being achieved in parallel with strategic and operational initiatives aimed at underpinning our continued growth for the next three to five years. We maintained our rapid pace of product development releases, with another three in 2016, further advancing our platform for enterprise utilization and flexibility, followed by version 11.1 which we released in February this year. 

 

This continued investment supports our growth strategy in two areas. One is to capitalize on existing client demand to expand their Accolade investment beyond product innovation to support Enterprise Initiative Management tracking and decision making. This market opportunity has been validated by Gartner's 2016 Market Guide for Strategy Execution Software and their recognition of Sopheon in this emerging space. We are also delighted to announce Sopheon's inclusion in Gartner's Magic Quadrant for Project Portfolio Management, just last week. Sopheon is the only vendor referenced in both the Market Guide for Strategy Execution Software and the Magic Quadrant for Project Portfolio Management. In Sopheon's view, this provides strong validation of our unique position and strength in the enterprise portfolio management, enterprise initiative management, and product development markets. The second growth area we continue to invest in is our vertical industry focus on chemical, consumer goods, food and beverage, aerospace and defense, and high-tech. In addition, we are researching the insurance, service and automobile industries as we have recently signed customers in these areas. Such customers help us to understand the value proposition Accolade can bring to new vertical markets, and to determine if these represent further new growth opportunities for the Company.

 

Following several years of clarifying our debt, equity and listing structure, our corporate activity has been relatively quiet in the past year, other than extension of the maturity of our debt facilities to January 2019.

 

Sopheon has a market-leading solution, global reach, solid financials, a clear corporate structure, an accelerating market, and most importantly great people - a real platform for growth. Full year revenue visibility for 2017 from contracted business and recurring revenue streams is now at $17.5m, compared to just under $17.0m at this time last year. This includes 20 license orders, up from 14 for the same period last year. This is a different mix compared to this time last year, which included a very substantial order from an existing enterprise tier customer. This is further evidence of the increased adoption of the Company's software and services from a broader range of businesses, including several with expected upside revenue later this year. Sopheon also continues its focus on working with and growing relationships with global blue chip customers such as Electrolux, PepsiCo, Proctor & Gamble and Merck. These factors, together with a strong sales pipeline, give the Board confidence in meeting our strategic and financial plans for the year, and in delivering continued positive development in our performance for 2017 and beyond.

 

 

 

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (corporate finance)

Mia Gardener (corporate broking)

finnCap

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFERRRIDIID
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.